Ken Griffin's position in Regenxbio is currently worth $2.75M. That's 0.00% of their equity portfolio (2304th largest holding). The first Regenxbio trade was made in Q3 2015. Since then Ken Griffin bought shares 51 more times and sold shares on 42 occasions. The investor's estimated purchase price is $4.45M, resulting in a loss of 38%.